UK markets open in 7 hours 11 minutes

Tarsus Pharmaceuticals, Inc. (TARS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
31.43-0.69 (-2.15%)
At close: 04:00PM EDT
31.43 0.00 (0.00%)
After hours: 05:35PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
16,154
17,447
25,816
57,027
0
Cost of revenue
531
1,593
955
2,075
0
Gross profit
15,623
15,854
24,861
54,952
0
Operating expenses
Research development
40,634
50,312
42,624
41,712
18,826
Selling general and administrative
37,088
108,700
44,949
25,397
8,172
Total operating expenses
77,722
159,012
87,573
67,109
26,998
Operating income or loss
-62,099
-143,158
-62,712
-12,157
-26,998
Interest expense
3,225
3,225
2,064
0
-
Total other income/expenses net
-1,071
274
-683
-1,651
-
Income before tax
-63,293
-135,893
-62,095
-13,772
-26,810
Income tax expense
50
0
-4
55
1
Income from continuing operations
-63,343
-135,893
-62,091
-13,827
-26,811
Net income
-63,343
-135,893
-62,091
-13,827
-26,811
Net income available to common shareholders
-63,336
-135,893
-62,091
-13,827
-26,811
Basic EPS
-3.84
-
-2.52
-0.67
-4.32
Diluted EPS
-3.84
-
-2.52
-0.67
-4.32
Basic average shares
27,726
-
24,620
20,554
6,207
Diluted average shares
27,726
-
24,620
20,554
6,207